Norwegian version of this page

How can Norway get more out of health data?

Norway Life Science 2024 gathers leading actors in health and life science, to find the solutions that will allow Norway to get more in return from the large investments in health research.

The logo for Norway Life Science 2024, and the logos of the partners Oslo Science City, Oslo University Hospital, NMBU – Norwegian University of Life Sciences, SINTEF, Association of the Pharmaceutical Industry in Norway, Oslo Cancer Cluster and The Life Science Cluster. Also the logos for the industry partners: Novartis, ThermoFisher, Roche, Novo Nordisk, Abbvie, GSK and AstraZeneca

Norway Life Science 2024 will take place on February 13 and 14.

On February 13 – 14, University of Oslo, together with Oslo Science City, Oslo University Hospital, NMBU – Norwegian University of Life Sciences, SINTEF, Association of the Pharmaceutical Industry in Norway, Oslo Cancer Cluster and The Life Science Cluster, welcome you to Norway's largest and most important conference for health and life science: Norway Life Science 2024.

See the programme and register

Unlocking the Potential of Health Data

The main theme of the conference is health data, and the aim is to help increase Norway's competitiveness in access to and use of such data. Compared to our European neighbouring countries, Norway gets less return from the large investments in health research in the form of patents, new companies, and export revenues from the health industry. Better access to health data for research and innovation, within clear ethical and privacy boundaries, will help strengthen Norwegian research environments, develop better treatments for patients, and create new jobs and export revenues.

– National, quality-based competition arenas have contributed to UiO having some of the country's foremost research environments in this field. To succeed with the ambition of developing a knowledge-based business community, cooperation within and across sectors is crucial. This conference facilitates that, says Svein St?len, rector at UiO.

Some highlights from the program

At the conference, you will hear from the leading research communities, key leaders in the Norwegian healthcare system, world-leading pharmaceutical companies, start-up environments, investors, and decision-makers. The entire value chain for health and life sciences are brought together.

  • Andrew Morris, Director of Health Data Research UK, will discuss how health data is used in pandemic preparedness and business development in the UK.
  • Henrik Ullum, Head of Statens Serum Institut in Denmark, Katarina Nystr?m, who investigated health data as a national resource for the Swedish government, and P?ivi Sillanaukee, Special Envoy for Health and Wellbeing in the Finnish Ministry of Health, will share success stories, challenges, and opportunities from our neighboring countries.
  • Boston Consulting Group will present the report "Establishing Norway as a health data leader – what will it take?" where they identify opportunities, obstacles, and concrete measures to make Norway internationally leading in the use of health data.
  • Several parallel sessions and panel discussions, including topics such as artificial intelligence, pandemic prevention, and precision medicine.

On day 2, we focus on health data and public-private collaboration, and draw inspiration from what Finland has achieved through the use of its data sources. We will also look at how Norway can attract investments and expertise. There will be a career event, Young Talents 2024, and a pitch competition for start-ups and innovation projects.

See the entire programme

Cooperation between researchers, industry, public actors, and investors

The conference is an Oslo Science City Arena event, with leading representatives of the health industry as industry partners.

– To develop a strong Norwegian health industry and rig the Norwegian health service for the future, we need to strengthen the cooperation between researchers, industry, public actors, and investors. Norway's first innovation district, Oslo Science City, is a platform for building this cooperation. And there is no better place to meet than here, in this innovation district where two thirds of health research in Norway is conducted, says Christine Wergeland S?rbye, Managing Director at Oslo Science City.

Published Dec. 5, 2023 12:00 PM - Last modified Dec. 5, 2023 12:49 PM